STOCK TITAN

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

(Neutral)
(Neutral)
Tags
conferences

Relay Therapeutics (Nasdaq: RLAY) announced that management will participate in two September 2026 investor fireside chats: the Wells Fargo Healthcare Conference on September 8, 2026 at 1:30 p.m. ET and the Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026 at 9:15 a.m. ET. Live webcasts and 30-day replays will be available via the company’s investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:

  • 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026 at 1:30 p.m. ET
  • Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026 at 9:15 a.m. ET

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease. Relay Therapeutics’ Dynamo® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The company’s lead clinical asset, zovegalisib, is the first pan-mutant selective PI3Kα inhibitor to enter clinical development and is currently in a Phase 3 clinical trial (ReDiscover-2) in HR+/HER2- metastatic breast cancer. Zovegalisib is also being investigated in a group of genetic disease indications called PI3Kα-driven vascular anomalies. Relay Therapeutics’ pipeline also includes programs for NRAS-driven solid tumors and Fabry disease. For more information, please visit www.relaytx.com or follow us on LinkedIn.

Contact:
Mitch Maisel
mmaisel@relaytx.com

Media:
Katie Engleman
1AB
919-333-7722
katie@1abmedia.com  


FAQ

When will Relay Therapeutics (RLAY) present at the 2026 Wells Fargo Healthcare Conference?

Relay Therapeutics will participate in a fireside chat at the 2026 Wells Fargo Healthcare Conference on September 8, 2026 at 1:30 p.m. ET. According to the company, investors can access a live webcast via its investor relations website.

What time is Relay Therapeutics (RLAY) at the Morgan Stanley 24th Annual Global Healthcare Conference 2026?

Relay Therapeutics is scheduled for a fireside chat on September 16, 2026 at 9:15 a.m. ET at the Morgan Stanley 24th Annual Global Healthcare Conference. According to the company, the session will be webcast live on its website.

How can investors listen to Relay Therapeutics (RLAY) September 2026 conference webcasts?

Investors can listen to the September 2026 fireside chats via live webcast on Relay Therapeutics’ website under News & Events > Events. According to the company, a direct link is available at its investor relations events and presentations page.

Will replays of the Relay Therapeutics (RLAY) September 2026 investor conferences be available?

Yes, archived replays of the September 2026 fireside chat webcasts will be available for up to 30 days. According to Relay Therapeutics, investors can access these replays through the News & Events section of its website.